ARTICLE ABSTRACT
Sharing patient-level data from clinical trials can improve the quality of research and our understanding of disease and medical treatments. Various concerns have been voiced about data sharing; they involve privacy, consent, intellectual property, costs, infrastructure, data standards, free-riding researchers, and potentially erroneous conclusions. Many of these concerns cannot be totally eliminated, but they can be mitigated and managed.
Link to access full article: www.nejm.org/doi/10.1056/NEJMp1608086
Also By
Frank Rockhold,
Perry Nisen,
Andrew Freeman
Please Sign in (or Register) to view further.